Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...

The raging war against data breaches poses an increasing challenge to healthcare organizations globally. As per current ...

On Tuesday, 20 May 2025, Regeneron Pharmaceuticals (NASDAQ:REGN) presented at the RBC Capital Markets Global Healthcare Conference ... Factor XI Program: This initiative aims to develop a safer ...

Illumina and Regeneron ... improving the health of our families and communities, and lowering the cost of care.” “Discoveries from smaller datasets before today’s AI have led to important ...

DNA sequencing company Illumina and biotech Regeneron have invested in electronic health record data company ... The new Truveta Genome Project initiative aims to generate genetic data on tens ...

Disclaimer: This is an AI-generated summary ... or copay assistance for Regeneron’s Products from third-party payors and other third parties, including private payor healthcare and insurance ...

Smarter Technologies is a new automation platform developed for hospitals and health systems ... able to move faster and more aggressively on AI initiatives.

Here’s a look at their latest initiatives: Apple is preparing to launch an AI-powered health service as part of an initiative called “Project Mulberry.” The service features an AI-driven ...

Drugmakers, including Regeneron, have committed to additional investments to boost production in the U.S. amid concerns about healthcare funding cuts and mass layoffs at the FDA. "Obviously ...